Varicella Virus Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines
Conditions: Varicella Interventions: Biological: Varicella Vaccine; Biological: Varivax Sponsors: Sinovac (Dalian) Vaccine Technology Co., Ltd. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Evaluate the Safety and Immunogenicity After MG1111 as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st SUDUVAX Inj. Vaccination
Condition: Varicella Interventions: Biological: MG1111 (BARICELA); Biological: VARIVAX; Biological: Suduvax Sponsor: Green Cross Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials

Evaluation of the Safety, Tolerability and Immunogenicity of VARIVAX ™ in Healthy Russians (V210-058)
Condition: Varicella Intervention: Biological: VARIVAX™ Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials